An experimental gene-editing therapy that aims to lower bad cholesterol for the long-term after a single infusion is off to a ...

(Peopleimages.com/YuriArcurs/Canva) For millions of people, statins are a daily shield against heart disease. But around 10 ...

Pharmaceutical companies have spent years targeting a common blood particle associated with heart-attack risks.

A one-time gene-editing infusion kept cholesterol levels low for a year, offering a potential new approach to preventing ...

If it continues to work in further studies, a gene therapy in development could eliminate the need for daily pills or regular ...

The long list of side effects marked on the packaging of statins can be a turn-off for those who might benefit from the cholesterol-lowering drugs. But a new study found only a few of those side ...

Regular follow-up calls from a pharmacist can help people lower their "bad" (LDL) cholesterol by reminding them to take their ...

Early CRISPR-based cholesterol therapy shows striking LDL reduction, but experts warn that safety, durability and off-target ...

LOS ANGELES (KABC) -- A powerful class of drugs proven to save the lives of many is being largely ignored by people under 40. The latest research examined the need for more young patients to take a ...

The Food and Drug Administration (FDA) warns that the popular cholesterol-lowering medications may cause memory loss and confusion, but long term use of the medications may reduce that risk.more In a ...

As we reach a certain age, many of us begin reaching for our pill bottles, as well as a nice glass of red. With more than 10 million people in England now eligible for statins, the cholesterol ...